EdiGene focuses on original innovations in gene editing, dedicated to developing disruptive cell and gene therapies
EdiGene focuses on original innovations in gene editing, dedicated to developing disruptive cell and gene therapies. The company operates platforms for RNA editing and immune compatibility, targeting therapies for genetic diseases and cancer.